News Pharma & Biotechnology

Cancer Vaccines Market Business Strategies and Forecast to 2027 – Top Companies Dendreon, ASTRAZENECA PLC., OSE Immunotherapeutics

The cancer vaccines market is expected to reach US$ 15,845.59 million by 2027 from US$ 4,568.82 million in 2019; the market is estimated to grow at a CAGR of 17.2% from 2020 to 2027.

The cancer vaccines assist in the treatment of the existing cancer or prevent the development of cancer; the former are known as therapeutic cancer vaccines. Several vaccines are “autologous,” as they are prepared from the samples obtained from cancer patients, and such vaccines are unique to that patient. Cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. Cervarix, Gardasil, Gardasil-9, and Hepatitis B (HBV) vaccine (HEPLISAV-B) are preventive cancer vaccines, whereas, Sipuleucel-T (Provenge) are therapeutic cancer vaccines. The global cancer vaccines market is driven by factors such as increasing R&D expenditures by pharmaceutical companies, and rising government support for research activities and clinical trials. However, the high cost of drug development hinders the market growth. However, emerging markets are creating growth opportunities for the market players.

Request Sample Pages of this research study at – https://www.theinsightpartners.com/sample/TIPRE00004595/

The Prominent/Emerging Players in the Cancer Vaccines Market Research include:

CSL Limited
ADURO BIOTECH INC.
Astellas Pharma Inc.
Merck & Co., Inc.
Sanofi
Bristol-Myers Squibb Company
Glaxosmithkline Plc.
Dendreon
ASTRAZENECA PLC.
OSE Immunotherapeutics

Global Cancer Vaccines Market – by Technology

Dendritic Cells Cancer Vaccines
Recombinant Cancer Vaccines
Antigen Cancer Vaccines
Whole Cell Cancer Vaccines
Viral Vector Cancer Vaccines

Global Cancer Vaccines Market – by Type

Preventive Cancer Vaccines
Therapeutic Cancer Vaccine

Global Cancer Vaccines Market – by Indication

Cervical Cancer
Prostate Cancer
Other Indications

Cancer Vaccines Market Segmented to 2027 – COVID-19 Impact and Global Analysis by Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines and Viral Vector Cancer Vaccines), Type (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer and Other Indications), End User (Pediatrics and Adults) and Geography.

Cancer is among the leading cause of deaths across the globe and is profoundly affecting the quality of life. Thus, cancer would be a burden on society if not diagnosed and treated on time. According to the World Health Organization (WHO), in 2018, approximately 9.6 million deaths reported across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the US.

Order a copy of this research study at – https://www.theinsightpartners.com/buy/TIPRE00004595/

ABOUT US:

The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact US:

If you have any queries about this report or would like further information, please contact us:

North America:+1 646 491 9876

Asia-Pacific:+91 20 6727 8686

Email: sales@theinsightpartners.com

Prashant Tambe
Prashant Tambe
An expert in SEO, Prashant carries an experience of over five years in the industry. He has the ability to analyze global industry trends that helps the leaders to make smarter decisions. An electrical, electronics and communication engineer, Prashant is able to predict future trends as they are changing fast with technological development.